Cortexin dosage and evidence

What is Cortexin?

How does Cortexin work?

It gives the brain a mix of peptides that are thought to support growth signals and protect brain cells.

What do people who took Cortexin report?

This is what real people say happened to them, good and bad. Nobody measured it. A report cannot tell a real effect from the lift people get just from expecting it to work, from a diet or training change made at the same time, or from what was really in the vial. We still put it near the top. It is the next best thing to a study in people: what happens when real people use it, including what goes wrong.

• Described use is by injection, into the muscle or under the skin, at around 10 mg a day for an adult, with some people describing spacing doses out further or halving them after an initial run.
• The most serious report in this material comes from someone who used it nasally in saline and describes bowel problems and intermittent rectal bleeding continuing for around six months, with no benefit. That is a single account rather than a pattern, but it is the most consequential thing anyone posted about this compound and it sits against a route nobody else describes using.
• The comparison people make constantly is against Cerebrolysin, and the comparison goes against this one. Experienced posters describe the other as substantially stronger and this one as not close.
• A recurring caution raised about the whole class is that prolonged or repeated courses may backfire because of the immune system, which is argued from theory in the threads rather than from anything anyone observed.
• Sourcing anxiety is explicit and unusually frank. People describe receiving minimally labelled packages from unverifiable manufacturers and openly question what is in them, which makes every report about this compound a report about an unknown product.
• Reports of no noticeable effect are present and the positive accounts are cautious rather than enthusiastic.

Sources: Brain Health threads on LongeCity comparing brain drugs given by injection, reached through site-restricted search extracts of the threads because the site itself would not load from this environment, September 2026. Nothing above is attributed to any specific post and no post is reproduced.

The evidence, in charts

The studies we cite

• Study in people2016
  Efficacy of cortexin in acute and recovery periods of hemispheric ischemic stroke

  This is the study Cortexin's reputation in stroke rests on, and almost nobody outside Russia has checked it. It looked at repeated short courses of a low dose in people recovering from a stroke. It was published in a Russian journal, inside a research tradition that has kept this drug in use there for decades. No team outside that tradition has repeated the result. Until one does, treat this as a claim rather than a finding.

  Russian clinical study of repeated low-dose Cortexin courses in stroke; not independently replicated outside Russia.

  PMID 27845314 Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
• Review of studies2015
  Cortexin. Molecular mechanisms and targets of neuroprotective activity

  A review. Cortexin is a freeze-dried extract of brain cortex with peptides, amino acids and trace minerals. It lists the brain targets it is thought to act on.

  Review describing Cortexin as a lyophilized cortical extract of neuropeptides, amino acids and trace elements with proposed neurotrophic targets.

  PMID 26356623 Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
• Animal study2021
  Neuroprotective action of Cortexin, Cerebrolysin and Actovegin in acute or chronic brain ischemia in rats

  In rats. The first head-to-head test against Cerebrolysin and Actovegin. Cortexin protected the brain in short-term and long-term models of low blood flow.

  First head-to-head rodent comparison; Cortexin showed neuroprotective activity in acute and chronic ischemia models.

  PMID 34260655 PLoS One